AssetMark Inc
PRCT icon

AssetMark Inc’s Procept Biorobotics PRCT Stock Holding History

AssetMark Inc’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$696K Buy
30,825
+6,707
+28% +$168K ﹤0.01% 1156
2026
Q1 		$603K Buy
24,118
+16,208
+205% +$457K ﹤0.01% 1132
2025
Q4 		$249K Buy
7,910
+340
+4% +$11.3K ﹤0.01% 1245
2025
Q3 		$270K Sell
7,570
-763
-9% -$34.8K ﹤0.01% 1204
2025
Q2 		$480K Buy
8,333
+407
+5% +$23K ﹤0.01% 1053
2025
Q1 		$462K Sell
7,926
-363
-4% -$24.8K ﹤0.01% 1002
2024
Q4 		$667K Buy
+8,289
New +$708K ﹤0.01% 916

Other funds holding PRCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

AssetMark Inc's PRCT Position: Q2 2026 in Review

AssetMark Inc increased its Procept Biorobotics (PRCT) stake by 28% in Q2 2026, buying an estimated $168K and bringing the position to 30,825 shares worth $696K. The position accounts for ﹤0.01% of the portfolio, ranked #1156.

AssetMark Inc first reported a position in PRCT in Q4 2024 and has held it in 7 quarters since. 254 funds tracked by Wall St. Rank hold PRCT as of Q2 2026.

  • AssetMark Inc held 30,825 shares of Procept Biorobotics worth $696K as of Q2 2026.
  • AssetMark Inc bought 6,707 Procept Biorobotics shares in Q2 2026, an estimated $168K.
  • Procept Biorobotics made up ﹤0.01% of AssetMark Inc's portfolio in Q2 2026, its #1156 holding.
  • AssetMark Inc first reported a position in Procept Biorobotics in Q4 2024 and has held it in 7 quarters since.
  • 254 funds tracked by Wall St. Rank held Procept Biorobotics as of Q2 2026.

Based on AssetMark Inc's 13F filing for Q2 2026, filed 30 Jul 2026.